Biomedical Engineering Reference
In-Depth Information
year 2012. However, by the year 2012, the Asia-Pacific biosensor market is expected to grow
to equal the U.S. $794 million market. The major market for biosensors is still the medical
diagnostic market with biosensors finding applications in blood gas analyzers, electrolyte
analyzers, metabolite analyzers, and glucose meters.
The report points out that glucose meters, as a management tool for diabetes have undergone
a dramatic change in the past few years. Some of the changes include wireless and sensor
technologies, and noninvasive glucose meters. By the year 2012, the U.S. market (the largest
one for glucose meters) is expected to grow to $1.28 billion
Market Research, 2008
. The
report further adds that in the year 2008, France and Germany together constituted 55.3%
of the biosensor market in Europe. By the year 2015, the environmental biosensor market
is expected to grow to U.S. $32.7 million in Germany.
The report also mentions that biosensor technology is being developed, amongst other
institutions at (in alphabetical order): AgMatrix, Inc., Cranfield Biotechnolgy Center,
LfeSensors, Inc., M-Biotech, and Nova Biomedical. The report also mentions that lead
manufacturers of biosensors include, once again, in alphabetical order: Abbott Point of Care,
Affinity Sensors, Animas Corporation, LifeScan, Inc., Medtronic Diabetes, Neo Sensors
Limited, Roche Diagnostics, and Science Healthcare Diagnostics.
Wei (2009)
in a personal communication (e-mail) has pointed out that Visiongain has
recently come out with a report entitled, “In-vitro diagnostics market report and analysis
2008-2023.” The report examines the commercial prospects for
in vitro
diagnostics (IVD)
in the global market. The report emphasizes that molecular diagnostics is increasing the
prospects of personalized medicine which should assist patients, companies, and healthcare
providers. The FDA (Food and Drug Administration) is also supporting IVD development.
Visiongain believes that the timing is right for the fostering of mutually beneficial part-
nerships. In its report Visiongain also used in-house forecasting techniques, and analysis of
drivers and constraints. The report also identified emerging and established key industrial
players. China and India were also included in their analysis. Visiongain predicts that the
market for IVD will exhibit strong growth during the period 2008-2023. Besides, far-sighted
companies and health-care providers will make significant investments in these IVD devices.
Furthermore, Visiongain predicts that molecular diagnostics, though still in its infancy, will
continue to make an increasing impact in the future of IVDs.
This is an expensive 240 page report with a three tier pricing: (a) individual copies £1499
(U.S. $2237, exchange rate 1 GBP (pound)
¼
1.492 U.S. dollars), departmental copy 2999
pounds (U.S. $4475), and whole company 4999 pounds (U.S. $7459).
Reports-research.com have recently come out with a SWOT (Strengths, Weaknesses,
Opportunities, and Threats) analysis on Universal Biosensors, Inc. Healthcare-Medical
Equipment. It is a market study (Marketstudie) and is published by Global Markets Direct.
